Latest News and Press Releases
Want to stay updated on the latest news?
-
New York, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain |...
-
Dublin, Aug. 08, 2025 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers an in-depth...
-
Dublin, May 28, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides"...
-
Dublin, March 18, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market Industry Trends and Global Forecasts to 2035: by Application Area, Type of Product Synthesized, Type of...
-
Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Therapeutics Market, Analysis and Forecast: 2025-2035" report has been added to ResearchAndMarkets.com's offering.Technological...
-
Dublin, Jan. 06, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Market: Forecast by Oligo Length, Application, Category, Type, Product, and Region, with Executive and Consultant Guides"...
-
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
-
Dublin, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market by Type (Gene silencing, Gene augmentation), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Therapeutic Area...
-
Dublin, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides. 2023 to 2027" report...
-
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides 2023 to 2027" report has...